"uuid:ID","id","text","instanceType","description","label","name"
"22712c93-c7b5-4e8c-a91c-18384e57f9b0","Objective_1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","OBJECTIVE","Main objective","","OBJ1"
"b4bd71b7-5981-433c-969e-2c3693ab0810","Objective_2","To document the safety profile of the xanomeline TTS.","OBJECTIVE","Safety","","OBJ2"
"0cbed610-d865-42cc-bb83-fbd0ccf08ae1","Objective_3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","OBJECTIVE","Behaviour","","OBJ3"
